Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
2.
Hautarzt ; 68(11): 890-895, 2017 Nov.
Article in German | MEDLINE | ID: mdl-28905116

ABSTRACT

BACKGROUND: Teledermoscopy is a promising modern technique to complement or to substitute dermatologic examination. OBJECTIVE: In this pilot study, we compared the outcomes of teledermoscopic consultations with clinical examinations and histologic results. METHODS: Conventional and dermatoscopic photos of single lesions were taken in 26 patients using a mobile phone and an attached handyscope optical system. Five resident physicians performed a clinical examination including dermoscopy while the teledermatologic and teledermoscopic photos were assessed by an experienced dermatologist. Examination results were compared regarding diagnosis, differential diagnoses, recommended further management, as well as subjective and objective accuracy of diagnosis. In addition, 23% of the lesions were excised and histologically examined. RESULTS: The most frequent diagnosis was "nevus cell nevus", followed by "subungual hematoma" and "basal cell carcinoma". The concordance of diagnoses was 92.3%; the concordance of recommended further management was 76.9%. Of the 6 histologically proven diagnoses, 66.7% were given the same diagnosis by teledermatoscopy and conventional clinical assessment. Concerning accuracy of diagnosis, teledermoscopy showed no disadvantage. CONCLUSIONS: Teledermatologic photos of single lesions combined with teledermatoscopic photos can be reliably and safely assessed. Especially when access to dermatologic examination is difficult, mobile teledermoscopy is a good and reliable alternative.


Subject(s)
Dermoscopy/instrumentation , Hematoma/diagnosis , Melanoma/diagnosis , Nevus, Pigmented/diagnosis , Skin Neoplasms/diagnosis , Smartphone , Telemedicine/instrumentation , Equipment Design , Germany , Humans , Melanoma/pathology , Nevus, Pigmented/pathology , Pilot Projects , Quality Assurance, Health Care , Reproducibility of Results , Skin/pathology , Skin Neoplasms/pathology
3.
Biomed Pharmacother ; 59(3): 70-5, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15795099

ABSTRACT

The activation of the coagulation system in cancer patients is a well-known phenomenon responsible for recurrent clinical problems. A number of fascinating molecular mechanisms have been recognized showing that the tumor not only activates the coagulation system, but vice versa, activated coagulation proteins are able to induce molecular effects in tumor cells. The molecular basis is the expression of defined membrane receptors by tumor cells that are activated, for example, by thrombin. As the liberation of thrombin from prothrombin is one of the key events in coagulation, it's impact upon biological processes, such as cancerogenesis and metastasation, seems to be a regular pathophysiological consequence. These perceptions are not only interesting for the comprehension of cancerogenesis, metastasation, and clinical phenomena, but they also have a high impact upon modern strategies of tumor therapy. Especially, the development of clinically useful coagulation inhibitors, such as modern low molecular weight heparins or melagatran, created the possibility of therapies that combine cell biological approaches with apoptosis-inducing principals such as chemotherapy. Several clinical studies that demonstrate the implication of these strategies have already been published recently. In this article the cell biological basics for these approaches are reviewed.


Subject(s)
Anticoagulants/therapeutic use , Blood Coagulation , Hemostatics/pharmacology , Neoplasms/complications , Receptors, Proteinase-Activated/drug effects , Thrombin/physiology , Thrombosis , Blood Coagulation/drug effects , Blood Coagulation/physiology , Female , Humans , Male , Neoplasm Metastasis , Thrombosis/etiology , Thrombosis/physiopathology , Thrombosis/prevention & control
4.
Gut ; 44(2): 246-52, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9895385

ABSTRACT

BACKGROUND: Mutations in endothelin 3 (EDN3) and endothelin B receptor (EDNRB) genes cause terminal colonic aganglionosis in mice, and mutations in these genes have also been linked to the terminal aganglionosis seen in human Hirschsprung's disease. However, details of EDN3 expression during embryogenesis are lacking, and consequently the cellular mechanism by which EDN3 regulates innervation of the terminal gut is unclear. AIMS: To localise the expression of EDN3 and EDNRB in the embryonic mouse gut. METHODS: Expression of EDN3 and EDNRB mRNA was analysed by reverse transcription polymerase chain reaction and in situ hybridisation. RESULTS: High levels of EDN3 mRNA expression were restricted to mesenchymal cells of the caecum before and after the arrival of neural crest cells. In contrast, EDNRB expression along the gut displayed a time dependent pattern similar to those of the protein tyrosine kinase ret and the neural crest cell marker PGP9.5. CONCLUSIONS: Mesenchymal cells of the caecum express high levels of EDN3 mRNA during embryogenesis and hence the production of EDN3 at the caecum is likely to act on neural crest cells as a paracrine factor necessary for subsequent innervation of the terminal gut.


Subject(s)
Cecum/embryology , Endothelin-3/metabolism , Mesoderm/metabolism , Animals , Embryonic and Fetal Development , Endothelin-3/genetics , Gene Expression , In Situ Hybridization , Intestinal Mucosa/metabolism , Intestines/embryology , Intestines/innervation , Mice , RNA, Messenger/genetics , Receptor, Endothelin B , Receptors, Endothelin/genetics , Reverse Transcriptase Polymerase Chain Reaction
5.
J Pediatr Surg ; 30(12): 1687-93, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8749925

ABSTRACT

Hirschsprung's disease (congenital colonic aganglionosis) is associated with abnormalities in the distributions and amounts of basement membrane and other extracellular matrix components in the human gut. The authors have investigated the possible significance of nidogen in Hirschsprung's disease, because this glycoprotein is necessary for the formation of ternary complexes with the other basement membrane components, laminin and collagen type IV, and thus may contribute the pathology of the disease. Increased nidogen immunoreactivity in the smooth muscle basement membranes and muscularis mucosae of the distal aganglionic zone in Hirschsprung's bowel was observed, the nidogen immunoreactivity demonstrating that the thickness of the muscularis mucosae was increased in this region. However, steady-state nidogen mRNA levels were found to be significantly lower in both proximal and distal Hirschsprung's bowel (relative to controls). In contrast, no significant differences were observed in the steady-state levels of the mRNAs coding for laminin subunits. These results indicate that although abnormalities in the amount or distribution of nidogen may contribute to the abnormalities seen in the extracellular matrix in Hirschsprung's disease, the levels of expression of the genes coding for either nidogen or laminin are unlikely to be primarily responsible for the lesions.


Subject(s)
Hirschsprung Disease/genetics , Membrane Glycoproteins/genetics , Basement Membrane/pathology , Gene Expression , Hirschsprung Disease/pathology , Humans , Infant , Intestinal Mucosa/pathology , Laminin/genetics , Muscle, Smooth/pathology , RNA, Messenger/genetics , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...